Remedent, Inc. Expects Revenues to Increase over $1 Million to Approximately $2.5 Million in Second Quarter Fiscal 2006

  
    
  
  
    
      Remedent, Inc. (OTC BB: REMI) 
      a leader in the research and development, manufacturing and marketing of 
      oral care and cosmetic dentistry products, announced that it expects 
      revenues for the second quarter 2006 to be approximately $2.5 million. 
      This represents an increase of more than $1 million over the second 
      quarter fiscal 2005 result. The Company further anticipates overheads 
      and margins to stay in line with the previous year.
    
    
      Guy De Vreese, Chairman of Remedent, stated, “We 
      are very pleased that we have achieved significant market penetration in 
      various European and Asian markets, and our selective efforts to grow 
      our footprint in America are on track.”
    
    
      He added, “The iWhite over-the-counter 
      business has grown with the signing of new distribution contracts 
      recently. These include deals with Pierre Fabre, Chefaro Italy and 
      Chefaro Spain, and Douglas Germany. We estimate that total retailers 
      served by these distributors will be roughly 19,000 and we have a goal 
      of being in at least 48,000 retail outlets. This business is also 
      expanding in China, with the signing of a distribution agreement with 
      Sephora China, and we are signing a distribution agreement with 
      Drugstore.com to help increase its cyberspace presence.”
    
    
      De Vreese further said, “We continue to 
      develop our professional treatment business. We have finished revamping 
      the new MetaTray in-office treatment. We see a shift of the business 
      towards the cosmetic market, and our revamping addressed that need. In 
      many markets, including the US, we are actively supporting this through 
      a number of OEM relationships. In the US, we are dealing with IMDS, a 
      California-based dealer that has started to target the cosmetic market. 
      In Europe, we are dealing with Universal Bright, an organization that 
      reaches out to the professional cosmetic treatment market.”
    
    
      De Vreese also said, “We are expanding our 
      range of products with a kit to treat sensitive teeth. The new product 
      is called ‘RemeSense,’ 
      and it will be offered to our existing retail channel. It is based on 
      the same technology currently used in our iWhite range of products. 
      RemeSense has a huge market potential because roughly a quarter of the 
      total population suffers from some form of tooth sensitivity. Moreover, 
      we have conducted a very successful patient test that demonstrates the 
      efficacy of the treatment.”
    
    
      De Vreese concluded, “After three years of 
      research and development, we are launching the Glamsmile veneer 
      business, a revolutionary instant smile service. We are supporting the 
      opening of two retail outlets, which will focus on veneer and whitening. 
      The first openings are in Beijing, China and Rotterdam, Holland. In 
      addition to the stores, the service will be made available to 
      affiliated, trained dentists in addition to the MetaTray treatment we 
      currently offer them.”
    
    
      Management of Remedent will host a conference call today at 10:00 A.M. 
      EDT. The call will include comments about the progress of its business 
      and provide guidance for the next 12-15 months. Those who wish to 
      participate in the call may telephone [phone], (US), or 
      973-935-2981, (international callers), passcode #7935948 approximately 
      15 minutes before the 10:00 A.M. EST starting time. If you cannot 
      participate in the call but wish to listen to it, you may login at 
      Remedent’s website at www.remedent.com. 
      You will be able to listen by either Windows Media or Real Player 
      approximately 2 hours after the completion of the call.
    
    
      About Remedent
    
    
      Remedent, Inc. strives to be a world leader in the research and 
      development, manufacturing and marketing of oral care and cosmetic 
      dentistry products. Remedent products are renowned for their 
      technological superiority and ease-of-use. Based in Deurle, Belgium and 
      El Segundo, CA, Remedent has successfully researched, developed and 
      manufactured all of its own products. These products are now distributed 
      in more than 35 countries worldwide. Remedent consists of two divisions: 
      one that serves the dental community and one that is focused on the 
      over-the-counter consumer market. Visit www.remedent.com 
      for further information.
    
    
      Certain matters discussed in this press release are “forward-looking 
      statements” intended to qualify for the safe 
      harbors from liability established by the Private Securities Litigation 
      Reform Act of 1995. In particular, the Company’s 
      statements regarding trends in the marketplace and potential future 
      results are examples of such forward-looking statements. The 
      forward-looking statements include risks and uncertainties, including, 
      but not limited to, the consummation and the successful integration of 
      proposed acquisitions, the timing of projects due to the variability in 
      size, scope and duration of projects, estimates made by management with 
      respect to the Company’s financial results, 
      backlog, critical accounting policies, regulatory delays, clinical study 
      results which lead to reductions or cancellations of projects, and other 
      factors, including general economic conditions and regulatory 
      developments, not within the Company’s 
      control. The factors discussed herein and expressed from time to 
      time in the Company’s filings with the 
      Securities and Exchange Commission could cause actual results and 
      developments to be materially different from those expressed in or 
      implied by such statements. The forward-looking statements are 
      made only as of the date of this press release and the Company 
      undertakes no obligation to publicly update such forward-looking 
      statements to reflect subsequent events or circumstance.
    
  
Remedent, Inc. (OTC BB: REMI) a leader in the research and
development, manufacturing and marketing of oral care and cosmetic
dentistry products, announced that it expects revenues for the second
quarter 2006 to be approximately $2.5 million. This represents an
increase of more than $1 million over the second quarter fiscal 2005
result. The Company further anticipates overheads and margins to stay
in line with the previous year.

   Guy De Vreese, Chairman of Remedent, stated, "We are very pleased
that we have achieved significant market penetration in various
European and Asian markets, and our selective efforts to grow our
footprint in America are on track."

   He added, "The iWhite over-the-counter business has grown with the
signing of new distribution contracts recently. These include deals
with Pierre Fabre, Chefaro Italy and Chefaro Spain, and Douglas
Germany. We estimate that total retailers served by these distributors
will be roughly 19,000 and we have a goal of being in at least 48,000
retail outlets. This business is also expanding in China, with the
signing of a distribution agreement with Sephora China, and we are
signing a distribution agreement with Drugstore.com to help increase
its cyberspace presence."

   De Vreese further said, "We continue to develop our professional
treatment business. We have finished revamping the new MetaTray
in-office treatment. We see a shift of the business towards the
cosmetic market, and our revamping addressed that need. In many
markets, including the US, we are actively supporting this through a
number of OEM relationships. In the US, we are dealing with IMDS, a
California-based dealer that has started to target the cosmetic
market. In Europe, we are dealing with Universal Bright, an
organization that reaches out to the professional cosmetic treatment
market."

   De Vreese also said, "We are expanding our range of products with
a kit to treat sensitive teeth. The new product is called 'RemeSense,'
and it will be offered to our existing retail channel. It is based on
the same technology currently used in our iWhite range of products.
RemeSense has a huge market potential because roughly a quarter of the
total population suffers from some form of tooth sensitivity.
Moreover, we have conducted a very successful patient test that
demonstrates the efficacy of the treatment."

   De Vreese concluded, "After three years of research and
development, we are launching the Glamsmile veneer business, a
revolutionary instant smile service. We are supporting the opening of
two retail outlets, which will focus on veneer and whitening. The
first openings are in Beijing, China and Rotterdam, Holland. In
addition to the stores, the service will be made available to
affiliated, trained dentists in addition to the MetaTray treatment we
currently offer them."

   Management of Remedent will host a conference call today at 10:00
A.M. EDT. The call will include comments about the progress of its
business and provide guidance for the next 12-15 months. Those who
wish to participate in the call may telephone [phone], (US), or
973-935-2981, (international callers), passcode #7935948 approximately
15 minutes before the 10:00 A.M. EST starting time. If you cannot
participate in the call but wish to listen to it, you may login at
Remedent's website at www.remedent.com. You will be able to listen by
either Windows Media or Real Player approximately 2 hours after the
completion of the call.

   About Remedent

   Remedent, Inc. strives to be a world leader in the research and
development, manufacturing and marketing of oral care and cosmetic
dentistry products. Remedent products are renowned for their
technological superiority and ease-of-use. Based in Deurle, Belgium
and El Segundo, CA, Remedent has successfully researched, developed
and manufactured all of its own products. These products are now
distributed in more than 35 countries worldwide. Remedent consists of
two divisions: one that serves the dental community and one that is
focused on the over-the-counter consumer market. Visit
www.remedent.com for further information.

   Certain matters discussed in this press release are
"forward-looking statements" intended to qualify for the safe harbors
from liability established by the Private Securities Litigation Reform
Act of 1995. In particular, the Company's statements regarding trends
in the marketplace and potential future results are examples of such
forward-looking statements. The forward-looking statements include
risks and uncertainties, including, but not limited to, the
consummation and the successful integration of proposed acquisitions,
the timing of projects due to the variability in size, scope and
duration of projects, estimates made by management with respect to the
Company's financial results, backlog, critical accounting policies,
regulatory delays, clinical study results which lead to reductions or
cancellations of projects, and other factors, including general
economic conditions and regulatory developments, not within the
Company's control. The factors discussed herein and expressed from
time to time in the Company's filings with the Securities and Exchange
Commission could cause actual results and developments to be
materially different from those expressed in or implied by such
statements. The forward-looking statements are made only as of the
date of this press release and the Company undertakes no obligation to
publicly update such forward-looking statements to reflect subsequent
events or circumstance.